Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present)
{{output}}
Introduction: Histone deacetylase (HDAC) inhibitors play a crucial role in restoring the balance of acetylation and deacetylation of lysine residues of histones and non-histone proteins, which are applied to treat several diseases including cancer.Area covered... ...